«VectivBio»
VectivBio
Company
VectivBio global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need.
Investors
Bpifrance
CADFEM
Cormorant Capital
Cowen Healthcare Investments
Eventide Asset Management
Inserm Transfert Initiative
Novo Holdings
OrbiMed
Palmarium
Surveyor Capital
Tekla Capital Management
Versant Ventures
Industry:
PharmTech
Headquarters:
Basel
Visit Website
info@vectivbio.com
https://twitter.com/vectivbio?lang=en
Register and Claim Ownership
(Reupload).png)
